Haneda, E.; Sato, A.; Suganuma, N.; Sebata, Y.; Okamoto, S.; Toda, S.; Kohagura, K.; Matsubara, Y.; Sugawara, Y.; Yamanaka, T.;
et al. Efficacy of Clinical Guidelines in Identifying All Japanese Patients with Hereditary Breast and Ovarian Cancer. Int. J. Environ. Res. Public Health 2022, 19, 6182.
https://doi.org/10.3390/ijerph19106182
AMA Style
Haneda E, Sato A, Suganuma N, Sebata Y, Okamoto S, Toda S, Kohagura K, Matsubara Y, Sugawara Y, Yamanaka T,
et al. Efficacy of Clinical Guidelines in Identifying All Japanese Patients with Hereditary Breast and Ovarian Cancer. International Journal of Environmental Research and Public Health. 2022; 19(10):6182.
https://doi.org/10.3390/ijerph19106182
Chicago/Turabian Style
Haneda, Eri, Ann Sato, Nobuyasu Suganuma, Yoshiko Sebata, Saki Okamoto, Soji Toda, Kaori Kohagura, Yuka Matsubara, Yuko Sugawara, Takashi Yamanaka,
and et al. 2022. "Efficacy of Clinical Guidelines in Identifying All Japanese Patients with Hereditary Breast and Ovarian Cancer" International Journal of Environmental Research and Public Health 19, no. 10: 6182.
https://doi.org/10.3390/ijerph19106182
APA Style
Haneda, E., Sato, A., Suganuma, N., Sebata, Y., Okamoto, S., Toda, S., Kohagura, K., Matsubara, Y., Sugawara, Y., Yamanaka, T., Yamashita, T., Shimizu, S., & Narimatsu, H.
(2022). Efficacy of Clinical Guidelines in Identifying All Japanese Patients with Hereditary Breast and Ovarian Cancer. International Journal of Environmental Research and Public Health, 19(10), 6182.
https://doi.org/10.3390/ijerph19106182
